Sema Yarman1, Yeliz Duvarci Ogret2, Fatma Savran Oguz2. 1. 1 Division of Endocrinology and Metabolic Diseases, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University , Çapa Istanbul, Turkey . 2. 2 Department of Medical Biology, Istanbul Faculty of Medicine, Istanbul University , Çapa Istanbul, Turkey .
Abstract
AIM: The aim of this study was to examine mutations in the aryl hydrocarbon receptor-interacting protein (AIP) gene by sequence analysis of exons 1-6 using leukocyte genomic DNA obtained from a cohort of familial isolated pituitary adenoma (FIPA) and apparent sporadic functional pituitary adenoma Turkish patients. METHODS: Fourteen FIPA and 90 sporadic pituitary adenoma (somatotrophinoma, prolactinoma, and corticotrophinoma) patients, 1 sporadic gigantism case, and 70 healthy controls were included in the study. RESULTS: We did not detect AIP mutations in patients with FIPAs or sporadic pituitary adenomas, including the gigantism case. Only two exonic homozygous missense single-nucleotide polymorphisms (rs641081 [Q228K] and rs4930195 [Q307R]) were identified in the AIP locus. Minor allele frequencies of the Q307R and Q228K variants were significantly higher in FIPA patients compared to controls. In addition, the minor allele frequency of the Q228K variant was significantly increased in patients with sporadic somatotrophinomas compared to controls, whereas the minor allele frequency of the Q307R variant was significantly increased in corticotrophinoma patients compared to controls. Conversely, the minor allele frequencies of Q228R and Q307R variants were similar between patients with prolactinomas and controls. No AIP gene mutation or variant was observed in the sporadic gigantism patient. These results suggest that Q228K and Q307R variants in the AIP gene might be involved in the genetic susceptibility to familial and sporadic pituitary adenomas (somatotrophinoma and corticotrophinoma) in the Turkish population.
AIM: The aim of this study was to examine mutations in the aryl hydrocarbon receptor-interacting protein (AIP) gene by sequence analysis of exons 1-6 using leukocyte genomic DNA obtained from a cohort of familial isolated pituitary adenoma (FIPA) and apparent sporadic functional pituitary adenoma Turkish patients. METHODS: Fourteen FIPA and 90 sporadic pituitary adenoma (somatotrophinoma, prolactinoma, and corticotrophinoma) patients, 1 sporadic gigantism case, and 70 healthy controls were included in the study. RESULTS: We did not detect AIP mutations in patients with FIPAs or sporadic pituitary adenomas, including the gigantism case. Only two exonic homozygous missense single-nucleotide polymorphisms (rs641081 [Q228K] and rs4930195 [Q307R]) were identified in the AIP locus. Minor allele frequencies of the Q307R and Q228K variants were significantly higher in FIPA patients compared to controls. In addition, the minor allele frequency of the Q228K variant was significantly increased in patients with sporadic somatotrophinomas compared to controls, whereas the minor allele frequency of the Q307R variant was significantly increased in corticotrophinoma patients compared to controls. Conversely, the minor allele frequencies of Q228R and Q307R variants were similar between patients with prolactinomas and controls. No AIP gene mutation or variant was observed in the sporadic gigantism patient. These results suggest that Q228K and Q307R variants in the AIP gene might be involved in the genetic susceptibility to familial and sporadic pituitary adenomas (somatotrophinoma and corticotrophinoma) in the Turkish population.
Authors: Maria A Tichomirowa; Anne Barlier; Adrian F Daly; Marie-Lise Jaffrain-Rea; Cristina Ronchi; Maria Yaneva; Jonathan D Urban; Patrick Petrossians; Atanaska Elenkova; Antoine Tabarin; Rachel Desailloud; Dominique Maiter; Thomas Schürmeyer; Renato Cozzi; Marily Theodoropoulou; Caroline Sievers; Ignacio Bernabeu; Luciana A Naves; Olivier Chabre; Carmen Fajardo Montañana; Vaclav Hana; Georges Halaby; Brigitte Delemer; José Ignacio Labarta Aizpún; Emmanuel Sonnet; Angel Ferrandez Longás; Marie-Thérèse Hagelstein; Philippe Caron; Günter K Stalla; Vincent Bours; Sabina Zacharieva; Anna Spada; Thierry Brue; Albert Beckers Journal: Eur J Endocrinol Date: 2011-07-13 Impact factor: 6.664
Authors: Outi Vierimaa; Marianthi Georgitsi; Rainer Lehtonen; Pia Vahteristo; Antti Kokko; Anniina Raitila; Karoliina Tuppurainen; Tapani M L Ebeling; Pasi I Salmela; Ralf Paschke; Sadi Gündogdu; Ernesto De Menis; Markus J Mäkinen; Virpi Launonen; Auli Karhu; Lauri A Aaltonen Journal: Science Date: 2006-05-26 Impact factor: 47.728
Authors: Chrysanthia A Leontiou; Maria Gueorguiev; Jacqueline van der Spuy; Richard Quinton; Francesca Lolli; Sevda Hassan; Harvinder S Chahal; Susana C Igreja; Suzanne Jordan; Janice Rowe; Marie Stolbrink; Helen C Christian; Jessica Wray; David Bishop-Bailey; Dan M Berney; John A H Wass; Vera Popovic; Antônio Ribeiro-Oliveira; Monica R Gadelha; John P Monson; Scott A Akker; Julian R E Davis; Richard N Clayton; Katsuhiko Yoshimoto; Takeo Iwata; Akira Matsuno; Kuniki Eguchi; Mâdâlina Musat; Daniel Flanagan; Gordon Peters; Graeme B Bolger; J Paul Chapple; Lawrence A Frohman; Ashley B Grossman; Márta Korbonits Journal: J Clin Endocrinol Metab Date: 2008-04-01 Impact factor: 5.958
Authors: Marianthi Georgitsi; Elina Heliövaara; Ralf Paschke; Ajith V K Kumar; Marc Tischkowitz; Outi Vierimaa; Pasi Salmela; Timo Sane; Ernesto De Menis; Salvatore Cannavò; Sadi Gündogdu; Anneke Lucassen; Louise Izatt; Simon Aylwin; Gul Bano; Shirley Hodgson; Christian A Koch; Auli Karhu; Lauri A Aaltonen Journal: J Clin Endocrinol Metab Date: 2008-07-15 Impact factor: 5.958
Authors: Medard F M van den Broek; Bernadette P M van Nesselrooij; Annemarie A Verrijn Stuart; Rachel S van Leeuwaarde; Gerlof D Valk Journal: Front Endocrinol (Lausanne) Date: 2019-12-10 Impact factor: 5.555